ABL Diagnostics (FRA:9BK0) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:9BK0 ABL Diagnostics FRA:9BK0
50 GF Score
Price €2.76
GF Value €7.33
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is ABL Diagnostics Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:9BK0 vs VEEV, BTSG, TEM: Short Interest Comparison

For the Health Information Services subindustry, ABL Diagnostics's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ABL Diagnostics Short Interest vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, ABL Diagnostics's Short Interest distribution charts can be found below:

* The bar in red indicates where ABL Diagnostics's Short Interest falls into.


FRA:9BK0
50GF Score
ABL Diagnostics FRA:9BK0
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is ABL Diagnostics (FRA:9BK0) Overvalued in 2026?

Based on GuruFocus' analysis, ABL Diagnostics stock appears to be undervalued. The current stock price of €2.76 is trading 62.3% below its estimated GF Value™ of €7.33. GuruFocus considers ABL Diagnostics to be Significantly Undervalued.

Key valuation signals for FRA:9BK0:

  • Short Interest:
  • GF Value™: €7.33 vs. price of €2.76 (62.3% below fair value)
  • GF Score™: 50/100 with 4 warning signs

No single metric tells the full story. See the FRA:9BK0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ABL Diagnostics Business Description

Other Exchanges ABLD:France
Address 72c, rue de, WOIPPY, Thionville, FRA, 57140
ABL Diagnostics is a diagnostic and medical software company. The group has focused on the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases. It also develops, manufactures, and markets kits for clinical specimen collection.
50GF Score

Get the complete analysis for FRA:9BK0

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.76
Price
€7.33
GF Value